Global Radioimmunotherapy Industry Research Report, Growth Trends and Competitive Analysis 2023-2029

Global Radioimmunotherapy Industry Research Report, Growth Trends and Competitive Analysis 2023-2029

Due to the COVID-19 pandemic, the global Radioimmunotherapy market size was US$ 1042.83 million in 2022 and is forecast to a readjusted size of US$ 4479 million by 2029 with a CAGR of 17.43% during the forecast period 2023-2029.

The global key companies of Radioimmunotherapy include Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope & Radiation, Curium Pharmaceuticals, and etc. In 2022, the global top five players hold a share approximately 99.25% in terms of revenue.

The United States Radioimmunotherapy market size was US$ 504.62 million in 2022, while China size was US$ 23.72 million. The proportion of the United States was 48.39% in 2022, while China percentage was 2.27%, and it is predicted that China share will reach 1.44% in 2029, trailing a CAGR of 20.26 % through the analysis period. As for the Europe Radioimmunotherapy landscape, Germany is projected to reach US$ 327 million by 2029.

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Radioimmunotherapy market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Radioimmunotherapy market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Radioimmunotherapy market. Readers of the report can become informed about current and future trends of the global Radioimmunotherapy market and how they will impact market growth during the forecast period.

By Company

On Market

Bayer

Novartis

Lantheus

Aurobindo Pharma

Mundipharma

China Isotope & Radiation

Curium Pharmaceuticals

On Pipeline

Gilead Sciences

Clarity Pharmaceuticals

Curasight

Nordic Nanovector

Philogen

RadioMedix

Telix Pharmaceuticals

Orano Med

Actinium Pharmaceuticals

Y-mAbs Therapeutics

Fusion Pharmaceuticals

Segment by Type

Beta-emitting

Targeted Alpha Therapy

Segment by Application

Non Hodgkin Lymphoma (NHL)

Solid Tumor

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Middle East & Africa

Middle East

Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.

Chapter 2: Revenue of Radioimmunotherapy in global and regional level.

Chapter 3: Detailed analysis of Radioimmunotherapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: Asia Pacific by Type, by Application and by region, revenue for each segment.

Chapter 9: Latin America by Type, by Application and by country, revenue for each segment.

Chapter 10: Middle East and Africa, by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radioimmunotherapy revenue, gross margin, and Business Strategy, etc.

Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 13: Research Findings and Conclusion